Safety and efficacy of intra-vitreal bevacizumab combined with supra-choroidal triamcinolone in the treatment of central retinal vein occlusion.

TITLE : SAFETY AND EFFICACY OF INTRAVITREAL BEVACIZUMAB COMBINED WITH SUPRACHOROIDAL TRIAMCINOLONE IN THE TREATMENT OF CENTRAL RETINAL VEIN OCCLUSION We have planned this study to determine the outcome of central retinal vein occlusion, in terms of decrease in macular edema and increase in visual acuity, after treatment with intravitreal Bevacizumab 0.05ml combined with supra-choroidal triamcinolone 0.05ml and also determines its safety in terms of intra-ocular pressure and infection. OBJECTIVE: To determine the safety and effectiveness of suprachoroidal triamcinolone 0.05ml in combination with intra-vitreal bevacizumab 0.05ml in eyes with central retinal vein occlusion. HYPOTHESIS: Suprachoroidal triamcinolone 0.05ml and intravitreal bevacizumab 0.05ml are both safe and effective when given in combination in the treatment of central retinal vein occlusion. Our study will continue for six months because the patients enrolled in our study in the month of September will need follow up till the month of December, as we have to give total 3 injections, 1 injection of both bevacizumab and triamcinolone every month for three months, and follow them every month and to see the response.